Biocentis Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 24

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $5.91M

  • Investors
  • 8

Biocentis General Information

Description

Operator of a genetic control technology designed to target harmful insect species that transmit diseases, destroy crops, and threaten biodiversity. The company offers innovative, precision-driven genetic techniques, enabling agriculture, public health, and environmental sectors to reduce the impact of insect-borne threats, fostering healthier ecosystems and improved crop yields.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 22 Glassworks Studios
  • Basing Place
  • London E2 8AB
  • England, United Kingdom
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Corporate Office
  • 22 Glassworks Studios
  • Basing Place
  • London E2 8AB
  • England, United Kingdom

Biocentis Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biocentis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 18-Nov-2025 $5.91M Completed Startup
6. Seed Round 18-Nov-2025 Completed Startup
5. Seed Round 01-Jan-2024 Completed Startup
4. Grant 14-Oct-2023 Completed Startup
3. Accelerator/Incubator 10-Jul-2023 Completed Startup
2. Seed Round 27-Jan-2022 $1.13M $1.13M Completed Startup
1. University Spin-Out 13-Jan-2022 Completed Startup
To view Biocentis’s complete valuation and funding history, request access »

Biocentis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed Preferred
Seed Preferred
Ordinary 119,199 $0.000116 $8.1 $8.1 1x $8.1 12.49%
To view Biocentis’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Biocentis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biocentis Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Algebris Asset Manager Minority
The Grantham Foundation Limited Partner Minority
Wellcome Trust Limited Partner
Corbites Venture Capital Minority
Novaterra Holding Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Biocentis FAQs

  • When was Biocentis founded?

    Biocentis was founded in 2022.

  • Where is Biocentis headquartered?

    Biocentis is headquartered in London, United Kingdom.

  • What is the size of Biocentis?

    Biocentis has 24 total employees.

  • What industry is Biocentis in?

    Biocentis’s primary industry is Biotechnology.

  • Is Biocentis a private or public company?

    Biocentis is a Private company.

  • What is Biocentis’s current revenue?

    The current revenue for Biocentis is .

  • How much funding has Biocentis raised over time?

    Biocentis has raised $13.9M.

  • Who are Biocentis’s investors?

    Algebris, The Grantham Foundation, Wellcome Trust, Corbites, and Novaterra Holding are 5 of 8 investors who have invested in Biocentis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process